Based on the expression status of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), BC is typically classified into four subtypes: Luminal A, Luminal B, HER2-enriched, and triple-negative breast cancer (3). This evidence concerns the gene ERBB2 and breast cancer.